Medical Oncologist
CION Cancer Clinics
PALB2 compared with BRCA: how serious is it? | CION Cancer Clinics
For breast cancer, a PALB2 fault is close to BRCA in seriousness. It is counted among the high-risk breast cancer genes, with a risk nearer BRCA2 than the milder genes. For ovarian cancer it is much gentler than BRCA1 or BRCA2. This page compares the two organ by organ, explains why family history weighs more with PALB2, and shows where plans differ. At CION Cancer Clinics, our oncologists explain what a gene result means for you and your family, and plan the checks that follow.
NG
Medically reviewed by Dr. Naresh GunduConsultant Medical Oncologist · MBBS, DNB (Internal Medicine), DM (Medical Oncology, AIIMS) · last reviewed September 2026, next review due September 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
- Is a PALB2 fault as serious as a BRCA fault?
- How does PALB2 compare with BRCA for each organ?
- How does a PALB2 result turn into a plan?
- Which words will you meet, in plain language?
- Where do PALB2 and BRCA plans actually differ?
- What this page cannot tell you
- Four things carriers tell us, and what is actually true
- Common questions about PALB2 and BRCA
The short answer
Is a PALB2 fault as serious as a BRCA fault?
For breast cancer, it comes close. PALB2 is counted among the high-risk breast cancer genes, and its risk sits nearer BRCA2 than the milder genes on a panel. For ovarian cancer, the picture is much gentler than with BRCA1 or BRCA2. So the honest answer is: as serious for the breasts, less so for the ovaries.
Why the two are so closely linked
PALB2 stands for partner and localiser of BRCA2. Inside the cell, it works hand in hand with BRCA1 and BRCA2 to repair a badly broken strand of DNA. When PALB2 is faulty, that repair team is short of a member. This is why the cancers it raises overlap so much with the BRCA genes.
Why the comparison matters to you
Families often hear PALB2 described as a lesser BRCA and relax, or as the same as BRCA and panic. Neither helps. The breast plan for a PALB2 carrier is usually close to a BRCA plan. Decisions about the ovaries are usually lighter, later and shaped more by the family history.
PALB2 is a real, high-risk finding for the breasts. It is not a diagnosis of cancer.Organ by organ
How does PALB2 compare with BRCA for each organ?
The comparison changes depending on which part of the body you are asking about.
Breasts
The risk is substantially raised, well above the general population and broadly similar to BRCA2. It is generally lower than BRCA1. A strong family history of breast cancer pushes a PALB2 carrier's own risk higher.
Ovaries
The risk is raised, but far less than with BRCA1 or BRCA2. Removing the ovaries is discussed later in life, if at all, and depends heavily on whether a relative has had ovarian cancer.
Pancreas
PALB2, like BRCA2, raises the risk of pancreatic cancer. The risk for any one carrier stays fairly low. Checks are usually considered only when a close relative has had pancreatic cancer.
Men in the family
Men can carry and pass on PALB2 exactly as they can BRCA.
What is known so far
- Male breast cancer risk is raised
- Pancreatic risk applies to men too
- Prostate risk is less certain than with BRCA2
Not sure whether this applies to you?
Ask an oncologistFrom result to plan
How does a PALB2 result turn into a plan?
-
The fault is confirmed as harmful
The report must call it pathogenic or likely pathogenic. A variant of uncertain meaning in PALB2 does not start a carrier's plan.
-
The family history is weighed carefully
With PALB2, the history counts for more than it does with BRCA1. Two carriers with different families can be given quite different risk estimates.
-
A breast plan is set, close to a BRCA plan
Most guidelines offer earlier and more frequent breast checks, with MRI considered. Preventive surgery is discussed as one option among several.
-
Ovaries and pancreas are decided on the history
If no relative had ovarian or pancreatic cancer, these conversations are usually lighter and come later than for a BRCA carrier.
-
Relatives are offered testing
Brothers, sisters and grown children each have a one-in-two chance of carrying the same fault, whichever parent it came from.
On your report
Which words will you meet, in plain language?
- PALB2
- A gene whose job is to guide BRCA2 to broken DNA so it can be repaired. A faulty copy weakens that repair.
- BRCA1 and BRCA2
- The two best-known breast and ovarian cancer genes. Most guidance on inherited breast cancer was first built around them.
- High-risk gene
- A gene whose fault raises cancer risk enough to change screening and prevention on its own. PALB2 is in this group for breast cancer.
- Moderate-risk gene
- A gene whose fault raises risk less sharply, so family history guides most decisions. CHEK2 and ATM are examples.
- Penetrance
- How often a fault actually leads to cancer across everyone who carries it. It is never all of them.
- Pathogenic
- A variant known to break the gene. This is what people mean by a positive result.
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
Side by side
Where do PALB2 and BRCA plans actually differ?
PALB2
BRCA1 and BRCA2
Breast risk high, broadly like BRCA2
Breast risk high, highest with BRCA1
Ovarian risk modestly raised
Ovarian risk clearly raised, most with BRCA1
Ovary removal discussed later, guided by history
Ovary removal usually advised once the family is complete
Drugs built around BRCA faults still being studied
Such drugs already used for several cancers
Evidence from fewer families, still growing
Decades of data from many countries
Being straight with you
What this page cannot tell you
It cannot give you your own risk. PALB2 risk estimates vary with the exact variant and, more than for most genes, with how many relatives had breast cancer. What your specific variant means is a question for the counsellor who ordered the test, who can run your family through a proper risk model.
The evidence is younger than for BRCA
PALB2 was linked to breast cancer well after BRCA1 and BRCA2. Fewer families have been followed, and very few come from India. Risk figures for the ovaries, pancreas and prostate may shift as more studies report. Treatment built around PALB2 is also at an earlier stage. Questions about drugs for a cancer already diagnosed belong under targeted therapy.
Who this does not apply to
If your report lists PALB2 as a variant of uncertain significance, none of this comparison applies yet. The same is true if PALB2 was simply on the panel and came back normal. Most women tested for breast cancer genes are in one of those two groups.
Commonly believed
Four things carriers tell us, and what is actually true
"PALB2 is a milder BRCA, so I can relax."
For the breasts, the risk is close to BRCA2 and guidelines treat it seriously. Earlier and closer breast checks are usually advised. Relaxing is not the right response.
"PALB2 means my ovaries must come out, like a BRCA carrier."
Not usually. The ovarian risk is far lower. Surgery on the ovaries is weighed later in life and mainly when a relative has had ovarian cancer.
"My BRCA test was negative, so PALB2 was checked too."
Not always. Older or smaller tests looked at BRCA1 and BRCA2 only. Check the list of genes printed on your report before assuming PALB2 was covered.
"PALB2 is a women's problem."
Men carry it and pass it on as often as women do. They also have a raised risk of breast and pancreatic cancer themselves. Leaving men out of family testing misses half the family.
Questions we are asked
Common questions about PALB2 and BRCA
Is PALB2 the same as BRCA3?
Some people call it that informally, because it works so closely with BRCA2 and raises breast risk in a similar way. It is not an official name. Your report will always say PALB2, and your plan is built for PALB2 specifically.
Do PALB2 carriers get the same breast MRI as BRCA carriers?
Usually a similar approach. Most guidelines recommend yearly breast imaging from a younger age than routine screening, with MRI considered. The exact starting point depends on your family history, and your counsellor puts it in writing.
Should a PALB2 carrier consider preventive mastectomy?
It is one option some carriers discuss, alongside close screening. The evidence for it is less developed than for BRCA, so the family history weighs heavily. It is a decision for a detailed conversation with your breast team, never a default.
Does PALB2 change how breast cancer is treated?
It can. Some drugs designed for BRCA-related cancers are being studied in PALB2 carriers, and early results are encouraging but based on small studies. This is a question for your oncologist, who will look at the cancer itself as well as the gene.
Can one person carry both a BRCA and a PALB2 fault?
It is rare, but it happens. Each fault is then managed on its own merits, and relatives need testing for both. Your counsellor will explain which side of the family each fault is likely to have come from.
What if my husband and I both carry PALB2?
A child who inherits two faulty copies can have a rare, serious childhood condition affecting the bone marrow. The chance is higher when partners are related by blood. If you are planning a family, ask your counsellor about testing your partner.
Is PALB2 found in Indian families?
Yes. Indian studies find PALB2 faults among women with breast cancer, usually less often than BRCA1 and BRCA2 but among the more frequent of the other genes. Most of this research is recent, and numbers from Telangana are still limited.
Will a PALB2 result affect my insurance?
India has no dedicated law on genetic discrimination in insurance, and the position is unsettled. Raise it with your counsellor before testing, not afterwards. Some people choose to arrange cover first.
Your Specialists
Meet CION's oncologists. Bring your family history or genetic report to them.
Our medical oncologists see people with a strong family history of cancer, arrange genetic counselling and testing where it fits, and plan the checks that follow.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- National Cancer Institute — BRCA Gene Changes: Cancer Risk and Genetic Testing
- National Cancer Institute — Genetics of Breast and Gynecologic Cancers (PDQ®)–Health Professional Version
- NCCN — Genetic/Familial High-Risk Assessment: Breast, Ovarian, Pancreatic, and Prostate
- New England Journal of Medicine — Breast-Cancer Risk in Families with Mutations in PALB2
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
Talk to us
Holding a PALB2 result and unsure what it means?
Bring your report and your family history, and we will help you understand how your plan compares with a BRCA carrier's. One helpline serves every CION centre.